Latest News

Nucleai and GoPath Diagnostics announce strategic collaboration

SIFTED – Clinical trials need a revamp — could Europe lead the charge?

Merck’s M Ventures supports Nucleai’s spatial AI biomarker technology for clinical trial enrolment

Nucleai and Altis Labs are transforming clinical trials through AI innovation

Carevive partners with Canopy Cancer Collective

Mika selected for White House initiative

Iktos and Elsevier announce their partnership

Concr secures Innovate UK funding to advance cancer precision therapy

Strategikon Closes Series A1 Funding Round to Modernize Clinical Trials Business Operations Worldwide